bluebird bio Inc. is a biotechnology company focused on developing gene therapies for severe genetic disorders. Their innovative approach uses gene editing technology to modify a patient’s own cells and treat conditions such as sickle cell disease and beta-thalassemia. With promising clinical trial results, bluebird bio is poised to revolutionize the field of genetic medicine.
